[go: up one dir, main page]

JPH0523755B2 - - Google Patents

Info

Publication number
JPH0523755B2
JPH0523755B2 JP60028396A JP2839685A JPH0523755B2 JP H0523755 B2 JPH0523755 B2 JP H0523755B2 JP 60028396 A JP60028396 A JP 60028396A JP 2839685 A JP2839685 A JP 2839685A JP H0523755 B2 JPH0523755 B2 JP H0523755B2
Authority
JP
Japan
Prior art keywords
cells
new
lymphokine
human
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP60028396A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61115026A (ja
Inventor
Masakazu Mihashi
Masashi Kurimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Priority to JP60028396A priority Critical patent/JPS61115026A/ja
Priority to US06/792,158 priority patent/US5019385A/en
Priority to KR1019850008229A priority patent/KR930004596B1/ko
Priority to GB8527466A priority patent/GB2168355B/en
Priority to FR858516536A priority patent/FR2572936B1/fr
Priority to CH4800/85A priority patent/CH664574A5/fr
Priority to AU49708/85A priority patent/AU603053B2/en
Priority to SE8505286A priority patent/SE468853B/sv
Priority to IT48762/85A priority patent/IT1184668B/it
Priority to ES548727A priority patent/ES8703161A1/es
Priority to DE3539775A priority patent/DE3539775C2/de
Priority to AT0327685A priority patent/AT395017B/de
Publication of JPS61115026A publication Critical patent/JPS61115026A/ja
Priority to ES556785A priority patent/ES8801582A1/es
Priority to US07/223,717 priority patent/US5003048A/en
Priority to US07/223,719 priority patent/US5030564A/en
Priority to US07/223,718 priority patent/US5002878A/en
Publication of JPH0523755B2 publication Critical patent/JPH0523755B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP60028396A 1984-11-09 1985-02-18 新リンホカイン２の製造方法 Granted JPS61115026A (ja)

Priority Applications (16)

Application Number Priority Date Filing Date Title
JP60028396A JPS61115026A (ja) 1985-02-18 1985-02-18 新リンホカイン２の製造方法
US06/792,158 US5019385A (en) 1984-11-09 1985-10-28 Novel lymphopine LK 2 and pharmaceutic compositions containing same
KR1019850008229A KR930004596B1 (ko) 1984-11-09 1985-11-05 신규 림포킨(lymphokine) 및 이에 대해 특이성을 갖는 모노클로날(monoclonal) 항체의 제조 방법
GB8527466A GB2168355B (en) 1984-11-09 1985-11-07 Novel lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses
ES548727A ES8703161A1 (es) 1984-11-09 1985-11-08 Un procedimiento para producir una linfocina (lk 2)
CH4800/85A CH664574A5 (fr) 1984-11-09 1985-11-08 Lymphokine et anticorps monoclonal specifique de ce lymphokine, leurs production et utilisations.
AU49708/85A AU603053B2 (en) 1984-11-09 1985-11-08 Novel lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses
SE8505286A SE468853B (sv) 1984-11-09 1985-11-08 Nytt lymfokin, monoklonala antikroppar specifika foer lymfokinet och deras framstaellning samt anvaendningar
IT48762/85A IT1184668B (it) 1984-11-09 1985-11-08 Linfochina,suo anticorpo specifico monoclonale e relativo procedimento di produzione
FR858516536A FR2572936B1 (fr) 1984-11-09 1985-11-08 Nouveau lymphokine et anticorps monoclonal specifique de ce lymphokine, leurs production et utilisations
DE3539775A DE3539775C2 (de) 1984-11-09 1985-11-09 Neues Lymphokin, gegen dieses Lymphokin spezifische Antikörper, Verfahren zu ihrer Herstellung und ihre Verwendung
AT0327685A AT395017B (de) 1984-11-09 1985-11-11 Verfahren zur herstellung eines neuen lymphokins (lk 2) sowie verwendung von lk 2 zur herstellung eines pharmazeutischen praeparates
ES556785A ES8801582A1 (es) 1984-11-09 1986-06-25 Un procedimiento para preparar una composicion farmaceutica de una linfocina (lk2).
US07/223,717 US5003048A (en) 1984-11-09 1988-07-21 Method for the purification of lymphokine LK 2
US07/223,719 US5030564A (en) 1984-11-09 1988-07-21 Monoclonal antibody specific to the lymphokine LK 2 and its method of production
US07/223,718 US5002878A (en) 1984-11-09 1988-07-21 Novel lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60028396A JPS61115026A (ja) 1985-02-18 1985-02-18 新リンホカイン２の製造方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP59236356A Division JPH0811759B2 (ja) 1984-11-09 1984-11-09 新リンホカイン▲ｉｉ▼とその製法および用途

Publications (2)

Publication Number Publication Date
JPS61115026A JPS61115026A (ja) 1986-06-02
JPH0523755B2 true JPH0523755B2 (sv) 1993-04-05

Family

ID=12247497

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60028396A Granted JPS61115026A (ja) 1984-11-09 1985-02-18 新リンホカイン２の製造方法

Country Status (1)

Country Link
JP (1) JPS61115026A (sv)

Also Published As

Publication number Publication date
JPS61115026A (ja) 1986-06-02

Similar Documents

Publication Publication Date Title
KR930000188B1 (ko) 신규 림포카인(lymphokine), 이 림포카인에 특이적인 모노클로날 항체 및 이들의 제조방법
KR930004596B1 (ko) 신규 림포킨(lymphokine) 및 이에 대해 특이성을 갖는 모노클로날(monoclonal) 항체의 제조 방법
JPS58107197A (ja) ツモアネクロシスフアクタ−の製造方法
JPS6245208B2 (sv)
KR950008569B1 (ko) 신규 림포카인(lymphokine) 및 그 제조방법과 사용방법
JP2532025B2 (ja) 新リンホカインｉｉｉを有効成分とする抗腫瘍作用を有するリンホカインの活性増強剤
JPH0214039B2 (sv)
JPH0523755B2 (sv)
RU2070046C1 (ru) Способ получения фактора, подавляющего метастазы
KR970002165B1 (ko) γ-인터페론의 제조방법과 그 용도
JPH0527640B2 (sv)
JPH0764744B2 (ja) 標的細胞障害性因子とヒトインタ−フェロンとを有効成分として含有する悪性腫瘍治療剤
JPH0574575B2 (sv)
JPH0446928B2 (sv)
JP2518634B2 (ja) ヒト ツモア・ネクロシス・フアクタ−の製造方法
JP2518635B2 (ja) ヒト ツモア・ネクロシス・フアクタ−
JPH0811759B2 (ja) 新リンホカイン▲ｉｉ▼とその製法および用途
JPH0526468B2 (sv)
JP2850293B2 (ja) γ−インターフェロン感受性疾患剤
JPH0532032B2 (sv)
JPS61115099A (ja) モノクロ−ナル抗体とその製法
JPS5889195A (ja) 標的細胞障害性因子の製造方法

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees